Release

Latest Research Reports on Stocks to Watch Bed Bath & Beyond and Rite Aid

12-23-release-2

December 23rd, 2016 – The post-election rally for the markets has eased as we head into the holidays. The Dow Jones Industrial Average fell 0.12 percent to close at 19,918.88, while the S&P 500 Index declined 0.19 percent to close at 2,260.96. The Dow Jones is up approximately 4.11 percent in December, in comparison the Dow fell 1.66 percent in December 2015. The index is on track to post its largest December gain since 2010, when the Dow Jones Industrial Average rose 5.2 percent. The S&P 500 Index has gained 10.61 percent in 2016, which has beat the 8 percent gain strategist predicted before the start of the year in a Reuters’ poll.

Register with us now for your free membership and gain access to our latest research reports at: www.rdinvesting.com/subscribe-today/

Bed Bath & Beyond Inc. (NASDAQ: BBBY)

Get Your Up-To-Date Bed Bath & Beyond Research Report at www.rdinvesting.com/company/BBBY

Bed Bath & Beyond’s shares declined 9.17 percent to close at $41.38 a share Thursday. The stock traded between $40.90 and $44.29 on volume of 13.85 million shares traded. Comparable sales declined 1.4 percent in the third quarter of fiscal 2016, up from a decline of 0.4 percent in the third quarter of fiscal 2015. The company reported net sales were approximately 2.955 billion for the third quarter of fiscal 2016, an increase of just 0.1 percent when compared to a year ago. Analysts polled by Thomson Reuters had expected sales of $3.05 billion. Shares of Bed Bath & Beyond have fallen approximately 14.2 percent year-to-date and are down roughly 9.5 percent in the past month.

Rite Aid Corporation (NYSE: RAD)

Get Your Up-To-Date Rite Aid Research Report at www.rdinvesting.com/company/RAD

Rite Aid’s shares declined 0.35 percent to close at $8.44 a share Thursday. The stock traded between $8.35 and $8.47 on volume of 18.79 million shares traded. The company reported revenues were $8.09 billion for the third quarter of fiscal 2017, a decrease of 0.8 percent year-over-year and short of expectations of $8.23 billion, according to analysts polled by Thomson Reuters. Same store sales for the quarter fell 3.4 percent year-over-year. “Reimbursement rates remain our largest challenge and we expect that to continue for the remainder of the fiscal year.” Said Chairman and CEO John Standley in the company’s earning’s release. Shares of Rite Aid have gained approximately 7.7 percent year-to-date and are up roughly 10.3 percent in the past month.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and reviewed by Hemal K. Gandhi, a CFA® charter holder. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.